Latest filing published 25 Nov 2019 for Nexien Biopharma, INC..
Filing timeline
BuySaleInsider track record
No signal scores available.
Jeffrey Friedland: trading record in brief
Jeffrey Friedland appears in our data through filings on Nexien Biopharma, Inc. shares, published by SEC (Form 4). Between 13 October 2017 and 22 November 2019, the trades on record add up to 12 filings.
The open-market record consists of 1 sale worth €379k, with no purchase. Since January 2019: no purchases and 1 sale on the market.
On 25 November 2019 came the latest disclosure, a transaction in Nexien Biopharma, Inc. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jeffrey Friedland
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 833,333 shares0Common StockSEC:0001214659-19-007389:0
- 228,800 shares0Common StockSEC:0001214659-19-007389:1
- 5,000,000 shares@ US$0.085Common StockSEC:0001144204-19-023082:0
- 1,166,667 sharesCommon StockSEC:0001214659-18-002063:0
- 20,800 shares@ US$0.25Common StockSEC:0001214659-18-001508:0
- 15,099,083 sharesCommon StockSEC:0001214659-17-007033:0
- 1,258,257 sharesCommon StockSEC:0001214659-17-007033:1
- 130,859 sharesCommon StockSEC:0001214659-17-007033:2
- 20,000,000 sharesCommon StockSEC:0001214659-17-006081:0
- 53,405,501 sharesCommon StockSEC:0001214659-17-006081:1
- 4,450,458 sharesCommon StockSEC:0001214659-17-006081:2
- 462,848 sharesCommon StockSEC:0001214659-17-006081:3
12 of 12 declarations